In some patients, concomitant use of these

Sildenafil tablets 125 mg are used to treat erectile dysfunction.
The medication enhances blood flow to the penis.
It’s important to follow prescribed dosages for safety.
Sildenafil can cause side effects like headache or dizziness.
Do not take sildenafil if you’re on nitrate medications.
Store tablets in a cool, dry place away from children.
The effect typically lasts for about 4-6 hours.
Consult your doctor before starting sildenafil treatment.

two drug classes can lower blood pressure

Sildenafil tablets 125 mg are generally well-tolerated.
Seek medical attention if you experience vision changes.
They are typically used on an as-needed basis.
Avoid heavy meals before taking sildenafil to improve absorption.
Sildenafil is not a cure for erectile dysfunction.
Pregnant women should avoid sildenafil use.
It is important to stay hydrated while using the medication.
Follow specific instructions provided by your healthcare provider.

significantly [see DRUG INTERACTIONS and CLINICAL PHARMACOLOGY]

Region	Average Cost per Pack	Pack Quantity	Notes
USA	$30 - $50	30 tablets	Generic versions available
UK	£15 - £25	30 tablets	Prescribed or OTC in some areas
India	₹150 - ₹300	10-30 tablets	Widely available, generic options
Australia	AUD 40 - AUD 70	30 tablets	Prescription required

leading to symptomatic hypotension

8.2 Lactation

There are no controlled clinical data on the safety or efficacy of VIAGRA in patients with retinitis pigmentosa (a minority of these patients have genetic disorders of retinal phosphodiesterases); if prescribed, this should be done with caution. Physicians should advise patients to stop taking PDE5 inhibitors, including VIAGRA, and seek prompt medical attention in the event of sudden decrease or loss of hearing. These events, which may be accompanied by tinnitus and dizziness, have been reported in temporal association to the intake of PDE5 inhibitors, including VIAGRA. It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors [see ADVERSE REACTIONS]. PDE5 inhibitors, including VIAGRA, and alpha-adrenergic blocking agents are both vasodilators with blood pressure lowering effects. (e.g., dizziness, lightheadedness, fainting).

For best results, take sildenafil on an empty stomach.
Eating fatty foods may delay its onset.
The medication should be taken approximately 30 minutes before activity.
Do not double dose to compensate for missed doses.
Keep regular medical appointments during treatment.
Report any worsening of symptoms to your doctor.
Never use sildenafil if experiencing chest pain without medical guidance.
Always follow the prescribed health regimen.

In those patients who are

Product	Dosage	Quantity + Bonus	Price
Viagra Generic	100mg	360 + 10 Pills	330.21€ 314.49€
Viagra Generic	150mg	180 + 10 Pills	236.46€ 225.20€
Viagra Generic	25mg	60 + 4 Pills	71.99€ 68.56€
Viagra Generic	150mg	60 + 4 Pills	111.25€ 105.95€
Viagra Generic	100mg	20 Pills	45.58€ 43.41€
Kamagra Polo	100mg	32 Pills	125.88€ 119.89€
Kamagra Soft Tabs	100mg	120 + 6 Pills	311.78€ 296.93€
Kamagra Soft Tabs	100mg	272 + 12 Pills	593.42€ 565.16€
Viagra Generic	200mg	10 Pills	40.96€ 39.01€
Viagra Generic	50mg	270 + 8 Pills	198.48€ 189.03€
Kamagra Oral Jelly	100mg	63 + 7 Sachets	224.18€ 213.50€
Kamagra Soft Tabs	100mg	84 + 4 Pills	233.05€ 221.95€
Viagra Generic	25mg	120 + 6 Pills	125.56€ 119.58€
Viagra Generic	50mg	60 + 4 Pills	83.93€ 79.93€

stable on alpha-blocker therapy, PDE5 inhibitors

Altitude illness

VIAGRA has systemic vasodilatory properties that resulted in transient decreases in supine blood pressure in healthy volunteers (mean maximum decrease of 8.4/5.5 mmHg), [see CLINICAL PHARMACOLOGY]. While this normally would be expected to be of little consequence in most patients, prior to prescribing VIAGRA, physicians should carefully consider whether their patients with underlying cardiovascular disease could be affected adversely by such vasodilatory effects, especially in combination with sexual activity. Use with caution in patients with the following underlying conditions which can be particularly sensitive to the actions of vasodilators including VIAGRA – those with left ventricular outflow obstruction (e.g., aortic stenosis, idiopathic hypertrophic subaortic stenosis) and those with severely impaired autonomic control of blood pressure. There are no controlled clinical data on the safety or efficacy of VIAGRA in the following groups; if prescribed, this should be done with caution. Patients who have suffered a myocardial infarction, stroke, or life-threatening arrhythmia within the last 6 months; Patients with resting hypotension (BP < 90/50 mmHg) or hypertension (BP > 170/110 mmHg); Patients with cardiac failure or coronary artery disease causing unstable angina.

Who should not take sildenafil?

Prolonged erection greater than 4 hours and priapism (painful erections greater than 6 hours in duration) have been reported infrequently since market approval of VIAGRA. VIAGRA should be used with caution in patients with anatomical deformation of the penis (such as angulation, cavernosal fibrosis or Peyronie's disease), or in patients who have conditions which may predispose them to priapism (such as sickle cell anemia, multiple myeloma, or leukemia). However, there are no controlled clinical data on the safety or efficacy of VIAGRA in patients with sickle cell or related anemias. Physicians should advise patients to stop use of all phosphodiesterase type 5 (PDE5) inhibitors, including VIAGRA, and seek medical attention in the event of a sudden loss of vision in one or both eyes. Based on published literature, the annual incidence of NAION is 2.5-11.8 cases per 100,000 in males aged ≥ 50.

Figure 3.5.1

An observational study evaluated whether recent use of PDE5 inhibitors, as a sildenafil 20 mg prescription class, was associated with acute onset of NAION. The results suggest an approximate 2 fold increase in the risk of NAION within 5 half-lives of PDE5 inhibitor use. From this information, it is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors [see ADVERSE REACTIONS]. Therefore, PDE5 inhibitors, including VIAGRA, should be used with caution in these patients and only when the anticipated benefits outweigh the risks. Individuals with “crowded” optic disc are also considered at greater risk for NAION compared to the general population, however, evidence is insufficient to support screening of prospective users of PDE5 inhibitors, including VIAGRA, for this uncommon condition. should be initiated at the

Sildenafil tablets 125 mg can be part of a broader ED treatment plan.
Psychological counseling may enhance effectiveness.
Combining therapies can improve outcomes.
Lifestyle modifications include weight management and exercise.
Quitting smoking can improve erectile health.
Vasodilator drugs should be avoided when using sildenafil.
Maintain a balanced diet alongside medication.
Support groups can offer additional assistance.

lowest dose [see DOSAGE AND ADMINISTRATION].

3. Dosage Forms and Strengths

Non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including permanent loss of vision, has been reported rarely post-marketing in temporal association with the use of phosphodiesterase type 5 (PDE5) inhibitors, including VIAGRA. Most, but not all, of these patients had underlying anatomic or vascular risk factors for developing NAION, including but not necessarily limited to: low cup to disc ratio (“crowded disc”), age over 50, diabetes, hypertension, coronary artery disease, hyperlipidemia and smoking [see WARNINGS AND PRECAUTIONS and PATIENT INFORMATION]. Urogenital: prolonged erection, priapism [see WARNINGS AND PRECAUTIONS and PATIENT INFORMATION], and hematuria. Administration of VIAGRA with nitric oxide donors such as organic nitrates or organic nitrites in any form is contraindicated. Consistent with its known effects on the nitric oxide/cGMP pathway, VIAGRA was shown to potentiate the hypotensive effects of nitrates [see DOSAGE AND ADMINISTRATION, CONTRAINDICATIONS, CLINICAL PHARMACOLOGY].

5.4 Visual Loss

Use caution when co-administering alpha-blockers with VIAGRA because of potential additive blood pressure-lowering effects. When VIAGRA is co-administered with an alpha-blocker, patients should be stable on alpha-blocker therapy prior to initiating VIAGRA treatment and VIAGRA should be initiated at the lowest dose [see DOSAGE AND ADMINISTRATION, WARNINGS AND PRECAUTIONS, CLINICAL PHARMACOLOGY]. When VIAGRA 100 mg was co-administered with amlodipine (5 mg or 10 mg) to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic [see WARNINGS AND PRECAUTIONS, sildenafil 100g CLINICAL PHARMACOLOGY]. It is therefore recommended not to exceed a maximum single dose of 25 mg of VIAGRA in a 48 hour period [see DOSAGE AND ADMINISTRATION, WARNINGS AND PRECAUTIONS, CLINICAL PHARMACOLOGY]. Co-administration of erythromycin, a moderate CYP3A4 inhibitor, resulted in 160% and 182% increases in sildenafil C and AUC, respectively.

Warnings for other groups

Co-administration of saquinavir, a strong CYP3A4 inhibitor, resulted in 140% and 210% increases in sildenafil C and AUC, respectively. A starting dose of 25 mg of VIAGRA should be considered in patients taking erythromycin or strong CYP3A4 inhibitors (such as saquinavir, ketoconazole, itraconazole) [see DOSAGE AND ADMINISTRATION, CLINICAL PHARMACOLOGY]. In a drug-drug interaction study sildenafil 50 mg given with alcohol 0.5 g/kg in which mean maximum blood alcohol levels of 0.08% was achieved, sildenafil did not potentiate the hypotensive effect of alcohol in healthy volunteers [see CLINICAL PHARMACOLOGY]. Included as part of the PRECAUTIONS section. Therefore, treatments for erectile dysfunction, including VIAGRA, should not be generally used in men for whom sexual activity is inadvisable because of their underlying cardiovascular status.

100mg Cenforce Gold Sildenafil Tablets